When Brand Messaging Breaks Down: What Patient Conversations Reveal

Sample programs are meant to speed up therapy starts.

But what happens when they slow them down?

For one global life sciences company, patient and provider conversations uncovered a disconnect in messaging that was creating confusion, delaying verification, and adding friction at a critical moment in the patient journey.

The Approach: Analyzing Real Conversations Across Stakeholders

To get a clearer picture, the team analyzed patient support conversations across multiple audiences, including patients, providers, and caregivers.

The goal was to understand what questions were being asked about the brand, where uncertainty was emerging, and how those gaps were impacting the experience, especially for new patients starting therapy through samples.

By examining a targeted set of conversations, they were able to identify patterns in confusion, breakdowns in the process, and moments where additional clarification was needed.

This approach made it possible to move beyond assumptions and see how messaging was actually being interpreted in real time.

What They Found: Confusion Was Concentrated Among HCPs

The analysis quickly revealed a clear pattern.

More than half of the calls were coming from healthcare providers, many of whom were unsure about next steps in the sampling and enrollment process.

• 53% of calls were from HCPs

• 34% were from patients

Rather than reinforcing clarity, the process was creating friction at a critical handoff point.

Providers and patients were struggling to navigate benefit verification requirements tied to sample access. As a result, what should have accelerated therapy initiation was introducing delays.

The Insight: Messaging Gaps Were Slowing Access to Therapy

These were not isolated questions. They pointed to a broader issue.

Key aspects of the program, particularly around enrollment and verification, were not being clearly communicated or consistently understood.

That gap forced providers and patients to rely on support channels to interpret next steps, adding time and complexity to the process.

In a moment designed to make therapy easier to start, messaging breakdowns were having the opposite effect.

The Impact: Clearer Messaging, Faster Access

With a better understanding of where confusion existed, the marketing team took action.

They refined program messaging to better support both providers and patients, ensuring that expectations, requirements, and next steps were clearer and easier to follow.

At the same time, they partnered cross-functionally to identify opportunities to improve how verification requests were handled and reduce unnecessary friction in the process.

The result was a meaningful improvement in speed and efficiency.

Verification timelines were reduced from an average of 30 days to 12 days, enabling faster access to therapy and a smoother experience for both HCPs and patients.

Why It Matters for Pharma

Brand messaging does more than inform. It shapes how patients and providers navigate access to therapy.

When that messaging is unclear or misaligned, it creates friction at the exact moments where speed and confidence matter most.

Patient and provider conversations offer a direct view into where those breakdowns occur.

Authenticx helps pharma teams use those insights to strengthen messaging, improve coordination, and remove barriers that delay treatment.